NEUP
Neuphoria Therapeutics Inc. NASDAQ Listed Dec 16, 2021$5.30
Mkt Cap $28.6M
52w Low $3.65
9.3% of range
52w High $21.40
50d MA $4.65
200d MA $6.62
P/E (TTM)
-22.7x
EV/EBITDA
36.7x
P/B
0.3x
Debt/Equity
0.0x
ROE
—
P/FCF
0.1x
RSI (14)
—
ATR (14)
—
Beta
0.48
50d MA
$4.65
200d MA
$6.62
Avg Volume
47.3K
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.
CIK (SEC)
Phone
781-439-5551
100 Summit Dr · Burlington · US
Data updated apr 26, 2026 2:45pm
· Source: massive.com